Who
Yong Yu
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Genelux.
In numbers
- Trades disclosed
- 57
- Buys
- 1
- Sells
- 21
- Bought
- $0
- Sold
- $3.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 17 Feb 2023
- Last trade
- 31 Aug 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Aug 2026filed 2 Sep 2026 | GNLX GeneluxBiotechnology | SEC FORM 4 Sold | $27K9,683 at $2.75 | filing |
| 31 Aug 2026filed 2 Sep 2026 | GNLX GeneluxBiotechnology | SEC FORM 4 Sold | $27K9,683 at $2.75 | filing |
| 4 Aug 2026filed 4 Aug 2026 | GNLX GeneluxBiotechnology | SEC FORM 4 Sold | $1,922653 at $2.94 | filing |
| 4 Aug 2026filed 4 Aug 2026 | GNLX GeneluxBiotechnology | SEC FORM 4 Sold | $1,920653 at $2.94 | filing |
| 16 Jun 2026filed 18 Jun 2026 | GNLX GeneluxBiotechnology | SEC FORM 4 Code A | —119,318 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | GNLX GeneluxBiotechnology | SEC FORM 4 Code A | —119,318 at $0.00 | filing |
| 11 May 2026filed 12 May 2026 | GNLX GeneluxBiotechnology | SEC FORM 4 Sold | $1,798605 at $2.97 | filing |
| 11 May 2026filed 12 May 2026 | GNLX GeneluxBiotechnology | SEC FORM 4 Sold | $1,797605 at $2.97 | filing |
| 24 Mar 2026filed 26 Mar 2026 | GNLX GeneluxBiotechnology | SEC FORM 4 Sold | $2,193906 at $2.42 | filing |
| 24 Mar 2026filed 26 Mar 2026 | GNLX GeneluxBiotechnology | SEC FORM 4 Sold | $2,193906 at $2.42 | filing |
| 17 Nov 2025filed 11 Dec 2025 | GNLX GeneluxBiotechnology | SEC FORM 4 Sold | $5,225973 at $5.37 | filing |
| 1 Sep 2025filed 3 Sep 2025 | GNLX Geneluxoption or derivative · Biotechnology | SEC FORM 4 Code D | —207,652 | filing |
| 1 Sep 2025filed 3 Sep 2025 | GNLX Geneluxoption or derivative · Biotechnology | SEC FORM 4 Code A | —207,652 | filing |
| 1 Sep 2025filed 3 Sep 2025 | GNLX Geneluxoption or derivative · Biotechnology | SEC FORM 4 Code D | —65,000 | filing |
| 1 Sep 2025filed 3 Sep 2025 | GNLX Geneluxoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 | filing |
| 27 Aug 2025filed 29 Aug 2025 | GNLX Geneluxoption or derivative · Biotechnology | SEC FORM 4 Code A | —134,520 at $0.00 | filing |
| 27 Aug 2025filed 29 Aug 2025 | GNLX GeneluxBiotechnology | SEC FORM 4 Code A | —101,480 at $0.00 | filing |
| 21 Aug 2025filed 11 Dec 2025 | GNLX GeneluxBiotechnology | SEC FORM 4 Sold | $11K3,219 at $3.36 | filing |
| 12 May 2025filed 13 May 2025 | GNLX GeneluxBiotechnology | SEC FORM 4 Sold | $16K5,579 at $2.92 | filing |
| 14 Mar 2025filed 17 Apr 2025 | GNLX GeneluxBiotechnology | SEC FORM 4 Code A | —13,350 at $0.00 | filing |
News
Hye Ryong Yu, Director, Korean Cultural Center in Hungaryxpatloop.com · 20 Oct 2026Genelux (NASDAQ:GNLX) Upgraded at Wall Street ZenGNLX · dailypolitical.com · 23 Oct 2026Head-To-Head Analysis: Foghorn Therapeutics (NASDAQ:FHTX) vs. Genelux (NASDAQ:GNLX)GNLX · themarketsdaily.com · 11 Oct 2026
1 headline in the last 90 days name Yong Yu; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.